In December 2021 Seneca’s EIS and VCT funds invested £1.4m into Aptamer Group to support its £80m IPO. Twelve months later the Company has moved into bespoke, state of the art premises and further established itself in the research, diagnostics and therapeutics sectors globally. The founders spoke with a journalist from The Guardian to discuss the considerable progress made to date.
Click below to read the article
Click below for Aptamer’s website